Broadfin Capital as of Sept. 30, 2018
Portfolio Holdings for Broadfin Capital
Broadfin Capital holds 47 positions in its portfolio as reported in the September 2018 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| iShares Russell 2000 Index (IWM) | 9.9 | $67M | 400k | 168.55 | |
| Iovance Biotherapeutics (IOVA) | 8.1 | $55M | 4.9M | 11.25 | |
| La Jolla Pharmaceuticl Com Par | 6.4 | $43M | 2.2M | 20.13 | |
| Zogenix | 4.8 | $33M | 658k | 49.60 | |
| Adma Biologics (ADMA) | 4.1 | $28M | 4.5M | 6.21 | |
| Retrophin | 4.0 | $27M | 938k | 28.73 | |
| Adamas Pharmaceuticals | 3.9 | $27M | 1.3M | 20.02 | |
| Tandem Diabetes Care (TNDM) | 3.6 | $25M | 573k | 42.84 | |
| Aratana Therapeutics | 3.5 | $24M | 4.1M | 5.84 | |
| Amarin Corporation | 3.5 | $24M | 1.5M | 16.27 | |
| Corium Intl | 3.3 | $23M | 2.4M | 9.51 | |
| Catalyst Pharmaceutical Partners (CPRX) | 2.9 | $19M | 5.1M | 3.78 | |
| Mirati Therapeutics | 2.5 | $17M | 358k | 47.10 | |
| Antares Pharma | 2.3 | $16M | 4.6M | 3.36 | |
| SPDR S&P Biotech (XBI) | 2.3 | $15M | 160k | 95.87 | |
| Nanostring Technologies (NSTGQ) | 2.2 | $15M | 850k | 17.83 | |
| Recro Pharma | 2.1 | $15M | 2.0M | 7.11 | |
| Pacific Biosciences of California (PACB) | 2.0 | $14M | 2.5M | 5.41 | |
| Integra LifeSciences Holdings (IART) | 1.9 | $13M | 197k | 65.87 | |
| Strongbridge Bioph shs usd | 1.8 | $12M | 2.6M | 4.85 | |
| Heron Therapeutics (HRTX) | 1.8 | $12M | 391k | 31.65 | |
| BioDelivery Sciences International | 1.8 | $12M | 4.4M | 2.80 | |
| Flamel Technologies Sa | 1.8 | $12M | 2.8M | 4.39 | |
| Teligent | 1.8 | $12M | 3.1M | 3.95 | |
| Xenon Pharmaceuticals (XENE) | 1.7 | $12M | 896k | 13.20 | |
| Tesaro | 1.3 | $9.0M | 230k | 39.01 | |
| Horizon Pharma | 1.2 | $8.0M | 411k | 19.58 | |
| Strata Skin Sciences | 1.1 | $7.7M | 2.2M | 3.54 | |
| Sierra Oncology | 1.0 | $7.0M | 4.1M | 1.70 | |
| Intersect Ent | 1.0 | $6.7M | 234k | 28.75 | |
| Sol Gel Technologies | 0.9 | $6.4M | 848k | 7.50 | |
| Livanova Plc Ord (LIVN) | 0.9 | $6.3M | 51k | 123.96 | |
| AngioDynamics (ANGO) | 0.9 | $6.3M | 289k | 21.74 | |
| Quotient | 0.9 | $6.1M | 805k | 7.55 | |
| Noveliontherapeuti.. | 0.8 | $5.8M | 1.9M | 2.96 | |
| Global Blood Therapeutics In | 0.8 | $5.7M | 150k | 38.00 | |
| Idera Pharmaceuticals | 0.8 | $5.6M | 629k | 8.91 | |
| Alnylam Pharmaceuticals (ALNY) | 0.8 | $5.4M | 62k | 87.52 | |
| Dex (DXCM) | 0.5 | $3.5M | 24k | 143.06 | |
| Kala Pharmaceuticals | 0.5 | $3.4M | 346k | 9.87 | |
| Pernix Therapeutics Hldgs In dbcv 4.250% 4/0 | 0.5 | $3.3M | 15M | 0.22 | |
| Kalvista Pharmaceuticals (KALV) | 0.5 | $3.3M | 150k | 22.11 | |
| Viewray (VRAYQ) | 0.3 | $2.3M | 250k | 9.36 | |
| Scynexis | 0.3 | $2.3M | 1.9M | 1.20 | |
| Alphatec Holdings (ATEC) | 0.3 | $2.3M | 670k | 3.37 | |
| Vericel (VCEL) | 0.3 | $1.9M | 133k | 14.15 | |
| Oncomed Pharmaceuticals | 0.1 | $424k | 200k | 2.12 |
